Atrial Fibrillation

Atrial fibrillation is the fast and chaotic beating of the atrial chambers or irregular heartbeart, which mainly affects older people. The risk of developing atrial fibrillation increases past the age of 60, mainly due to the wear and tear that may affect the heart's function as a person ages.

Follow the links below to find information on atrial fibrillation.

Reviewed October 2011

Related HealthInsite Topics

Systematic Reviews of Treatments for Atrial Fibrillation

HealthInsite Topic Page
Links to systematic reviews of the evidence for the effectiveness of therapies for atrial fibrillation.

14 Resources Found

Results 1 to 14 displayed.

Title:   New Stroke Prevention Medicine
Publisher:   HealthInsite Editorial Team
Description:   Dabigatran (Pradaxa), a new anticoagulant medicine to help prevent strokes in people with an irregular heartbeat (atrial fibrillation), is reviewed in the latest edition of Medicine Update, an online newsletter published by NPS: Better choices, Better health.
Date:   Aug 2011
Title:   Dabigatran (Pradaxa) for preventing stroke in people with atrial fibrillation
Publisher:   National Prescribing Service
Description:   This Medicine Update is about using dabigatran to prevent stroke in people with a condition called atrial fibrillation. Dabigatran can also be used after hip or knee replacement surgery (see the April 2010 Medicine Update issue).
Date:   Aug 2011
Title:   Current management of atrial fibrillation
Publisher:   Australian Prescriber
Description:   Atrial fibrillation is a common condition and carries the risk of cerebral thromboembolism.The CHADS2 score is often used to stratify this risk.
Date:   Aug 2011
Title:   Heart conditions - atrial fibrillation
Publisher:   Better Health Channel
Description:   Atrial fibrillation (AF) is a type of heart irregularity (arrhythmia). The heart beats both fast and abnormally and this can cause palpitations or a fluttering heartbeat, irregular heartbeat, chest pains, dizziness or fainting spells. AF can remain undetected for long periods of time. Untreated, complications may include stroke and heart attack. Treatment options include medication, surgery and electric shock therapy. An artificial pacemaker may be inserted to maintain regular heart rhythm.
Date:   Jul 2011
Title:   Stroke prevention for high risk groups
Publisher:   Better Health Channel
Description:   Certain conditions such as hypertension (high blood pressure), atrial fibrillation (irregular heartbeat) and atherosclerosis (hardening of the arteries) can substantially increase a person's risk of stroke. Methods of reducing the risk include medications, surgery and lifestyle changes.
Date:   Apr 2011
Title:   Cardiac ablation for the treatment of atrial fibrillation
Publisher:   Virtual Medical Centre.com
Description:   Cardiac ablation for the treatment of heart rhythm disorder is a procedure in which radiofrequency energy is used to destroy (or ablate) abnormal tissue in the heart.
Date:   Mar 2011
Title:   Atrial fibrillation (AF)
Publisher:   Virtual Medical Centre.com
Description:   Atrial fibrillation (AF) is a disorder of the rhythm of the heart. It results from disorganised electrical activity in the atria of the heart, which causes rapid stimulation of the ventricles, leading to an irregular pulse rate. AF is the most common sustained cardiac arrhythmia.
Date:   Mar 2011
Title:   Atrial fibrillation - myDr.com.au
Publisher:   myDr
Description:   Atrial fibrillation (AF) is a type of irregular heartbeat that can increase the risk of stroke. Find out about the causes, symptoms and treatment of atrial fibrillation.
Date:   Jan 2010
Title:   Arrhythmia
Publisher:   HealthInsite Topic Page
Description:   Links to information arrhythmia, including palpitations, Long QT Syndrome and atrial fibrillation.
Date:   Mar 2007
Title:   The management of people with atrial fibrillation and flutter
Publisher:   New Zealand Guidelines Group (NZGG)
Description:   The purpose of this guideline is to provide an evidence-based summary of effective practice in the assessment and management of atrial fibrillation (AF) and atrial flutter (AFL) in New Zealand.
Date:   May 2005
Title:   The management of people with atrial fibrillation and flutter summary
Publisher:   New Zealand Guidelines Group (NZGG)
Description:   Atrial fibrillation (AF) is common and increases with age (the overall prevalence in the general population isabout 1%, but the prevalence in people aged over 80 years is close to 10%).
Date:   May 2005
Title:   Warfarin: balancing the benefits and harms
Publisher:   Australian Prescriber
Description:   The benefits of warfarin therapy are substantial in the prevention of arterial and venous thrombosis, and in the primary and secondary prevention of stroke related to non-rheumatic atrial fibrillation. The major risk of warfarin is bleeding, which can cause significant morbidity or mortality.
Date:   Aug 2004
Title:   Atrial fibrillation
Publisher:   Australian Prescriber
Description:   In the normal heart, the muscles of the upper chambers (atria) contract regularly. If these regular contractions are replaced by fast and irregular twitching the person has developed atrial fibrillation which makes their pulse fast and irregular.
Date:   Jan 2000
Title:   Contemporary management of atrial fibrillation
Publisher:   Australian Prescriber
Description:   Atrial fibrillation is responsible for considerable morbidity in our population. Management of persistent atrial fibrillation of acute onset involves electrical or pharmacological cardioversion to restore sinus rhythm and the use of antiarrhythmic drugs to maintain sinus rhythm.
Date:   Jan 2000

Results 1 to 14 displayed.